Duygen Tablet 30/2.5 mg (Pimasartan Potassium Trihydrate, Amlodipine Besilate)
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
CTC Bio, Co., Ltd.
MFDS item code 202300137 · Approved 2023.01.06
This product's status changed to Approval withdrawn on 2025.08.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension inadequately controlled with fimasartan monotherapy
This medication can effectively control blood pressure and prevent complications in patients with essential hypertension whose blood pressure is not adequately controlled with pimasartan potassium monotherapy. It provides assistance in cases where blood pressure control is difficult and contributes to the stable management of the patient's blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.
This drug may cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Those allergic to this drug's active ingredients or similar drugs, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severely impaired liver function, those with biliary obstruction, and patients with certain kidney diseases should not take this medication. Patients with low blood volume or sodium deficiency, impaired kidney function, renal artery hypertension, certain heart valve diseases, severe hypotension, and elderly patients should use this medication cautiously and be closely monitored for the possibility of side effects. Side effects may include dizziness, headache, swelling of the face or limbs, urinary disturbances, insomnia, and flushing. In severe cases, acute renal failure or heart problems may occur. As hypotensive symptoms may occur, patients taking diuretics or those with low sodium levels should be careful when starting this medication or increasing the dosage; if symptoms worsen, the patient should be laid down and intravenous fluids may be necessary. This drug may raise blood potassium levels, so patients with heart disease or kidney disease should regularly check potassium levels through blood tests. There may be interactions when taken with other antihypertensive medications or specific drugs, so if other medications are being taken, it is essential to consult with a doctor or pharmacist. Pregnant and breastfeeding women are advised to avoid taking this medication and should consult with a doctor beforehand if necessary. Safety for children and the elderly has not been adequately established, so special caution is needed. Overdosage may lead to hypotension and cardiac arrhythmias, which may require emergency treatment. This medication should be kept out of reach of children, and transferring it to another container may adversely affect its quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a tightly closed container that blocks light. It is also important to store it at a temperature between 1°C and 30°C to maintain the drug's efficacy.
White, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
CTC Bio, Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.